Understanding brain tumors caused by specific genetic mutations

Modeling IDH Mutant Gliomas by Genetic Engineering of Brain Organoid

NIH-funded research Birmingham VA Medical Center · NIH-10951520

This study is looking at how certain gene changes in brain tumors called gliomas affect their growth, using special lab-grown brain models to find new ways to treat these tumors, which could help patients in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBirmingham VA Medical Center NIH-funded
Lab location1 site (Birmingham, United States)
Project IDNIH-10951520 on NIH RePORTER

What this research studies

This research investigates the mechanisms behind gliomas, a type of brain tumor, particularly focusing on mutations in the IDH1 and IDH2 genes. By using brain organoids derived from human pluripotent stem cells, the study aims to create a model that mimics the human brain environment, allowing researchers to explore how these mutations contribute to tumor development. The goal is to identify new therapeutic targets that could lead to better treatments for gliomas. Patients may benefit from insights gained through this research, which could inform future treatment strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults diagnosed with gliomas, particularly those with IDH mutations.

Not a fit: Patients with gliomas that do not have IDH mutations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel therapies for gliomas, improving outcomes for patients with this challenging condition.

How similar studies have performed: Previous research has shown promise in using organoid models to study various cancers, suggesting that this approach could yield valuable insights into glioma biology.

Where this research is happening

Birmingham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.